Who are CorMedix Inc.'s main suppliers?

CorMedix Inc. (CRMD) key suppliers include: ORANY, ORANY. View the full supplier network at chainsifter.com/chain/CRMD.

Who are CorMedix Inc.'s major customers?

CorMedix Inc. (CRMD) key customers include: DIALYSIS-ORGANIZATION, TOP-THREE-CUSTOMERS, ORANY, ORANY. View the full customer network at chainsifter.com/chain/CRMD.

What sector is CorMedix Inc. in?

CorMedix Inc. (CRMD) operates in the general sector. ChainSifter tracks its verified supply chain relationships including suppliers, customers, and strategic partners.

CRMD Supply Chain: CorMedix Inc. Suppliers & Customers

2Suppliers

4Customers

3Debt Items

20Related Chains

CorMedix Inc. Suppliers

Ticker	Name	Confidence	Evidence
ORANY	ORANY	72%	Reciprocal relationship from ORANY graph: Reciprocal relationship from CRMD graph: Reciprocal relationship from ORANY graph: Reciprocal relationship from CRMD graph: Reciprocal relationship from ORAN…
ORANY	ORANY	72%	e pharmaceutical ingredients (“APIs”) for DefenCath, taurolidine and heparin sodium, respectively. With regards to taurolidine, we have a drug master file (“DMF”) filed with the FDA. There is a maste…

CorMedix Inc. Customers

Ticker	Name	Confidence	Evidence
DIALYSIS-ORGANIZATION	DIALYSIS-ORGANIZATION	92%	DefenCath sales increased year over year largely due to the onboarding of a large dialysis organization in mid-2025
TOP-THREE-CUSTOMERS	TOP-THREE-CUSTOMERS	92%	Sales to our top three customers accounted for 79% of our total revenue for the year ended December 31, 2025
ORANY	ORANY	72%	ices. Further, the development of new treatment methods could render DefenCath non-competitive or obsolete. We believe that the key competitive factors that will affect the commercial success of Defe…
ORANY	ORANY	72%	Reciprocal relationship from ORANY graph: Reciprocal relationship from CRMD graph: ices. Further, the development of new treatment methods could render DefenCath non-competitive or obsolete. We belie…

CorMedix Inc. Debt Obligations

Instrument	Description	Confidence	Evidence
CRMD-DEBT-8858	Warrants outstanding: 3310000	90%	xbrl warrant detail from xbrl 2025-12-31.
CRMD-DEBT-8859	Xbrl Convertible	90%	xbrl convertible detail from xbrl 2025-12-31.
CRMD-DEBT	Debt stack $147.4M	90%	Market cache reports total debt of $147.4M.

CorMedix Inc. Acquisitions

No acquisitions on recordNo completed or pending acquisitions found in our database for CorMedix Inc..

CorMedix Inc. Ownership

Holder	Name	Confidence	Evidence
CRMD-OWNER-DEEP-TRACK-CAPITAL-LP	Deep Track Capital, LP	90%	13F overlay lists Deep Track Capital, LP as top holder; 192 tracked holders.

CorMedix Inc. Extended Supply Chain Network

Ticker	Name	Chain Index	Hops	Relationship Types
ELUT	Elutia Inc.	100.00	2
OVID	Ovid Therapeutics Inc.	100.00	2
OBIO	Orchestra BioMed Holdings, Inc.	100.00	2
LONA	LeonaBio, Inc.	100.00	2
ORANY	ORANGE	100.00	1	['customer', 'supplier']
AGEN	Agenus Inc.	100.00	2
VKTX	Viking Therapeutics, Inc.	100.00	2
SGMO	Sangamo Therapeutics, Inc.	100.00	2
PLX	Protalix BioTherapeutics, Inc.	100.00	2
D	Dominion Energy, Inc.	50.00	2
DNTH	Dianthus Therapeutics, Inc.	50.00	2
CLNE	Clean Energy Fuels Corp.	50.00	2
FENC	Fennec Pharmaceuticals Inc.	50.00	2
EQR	Equity Residential	50.00	2
AYTU	Aytu BioPharma, Inc.	50.00	2
AMZE	Amaze Holdings, Inc.	50.00	2
CHUC	Charlie's Holdings, Inc.	50.00	2
SCNX	Scienture Holdings, Inc.	50.00	2
DFTX	Definium Therapeutics, Inc.	50.00	2
CPRX	Catalyst Pharmaceuticals, Inc.	50.00	2

CorMedix Inc. Supply Chain